Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.

Kunisada K, Hirota H, Fujio Y, Matsui H, Tani Y, Yamauchi-Takihara K, Kishimoto T.

Circulation. 1996 Nov 15;94(10):2626-32. Erratum in: Circulation 1997 Apr 1;95(7):1975.

2.

Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes.

Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, Kishimoto T.

Circulation. 1998 Jul 28;98(4):346-52.

3.

Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes.

Oh H, Fujio Y, Kunisada K, Hirota H, Matsui H, Kishimoto T, Yamauchi-Takihara K.

J Biol Chem. 1998 Apr 17;273(16):9703-10.

4.

Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes.

Fujio Y, Kunisada K, Hirota H, Yamauchi-Takihara K, Kishimoto T.

J Clin Invest. 1997 Jun 15;99(12):2898-905.

5.

Signaling pathway of ciliary neurotrophic factor in neuroblastoma cell lines.

Kuroda H, Sugimoto T, Horii Y, Sawada T.

Med Pediatr Oncol. 2001 Jan;36(1):118-21.

PMID:
11464862
7.

Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes.

Tone E, Kunisada K, Fujio Y, Matsui H, Negoro S, Oh H, Kishimoto T, Yamauchi-Takihara K.

Biochem Biophys Res Commun. 1998 Dec 9;253(1):147-50.

PMID:
9875235
8.

gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.

Tone E, Kunisada K, Kumanogoh A, Negoro S, Funamoto M, Osugi T, Kishimoto T, Yamauchi-Takihara K.

Cytokine. 2000 Oct;12(10):1512-8.

PMID:
11023666
10.

Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes.

Kodama H, Fukuda K, Pan J, Makino S, Baba A, Hori S, Ogawa S.

Circ Res. 1997 Nov;81(5):656-63.

11.
12.

Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.

Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H.

Circulation. 2003 Feb 18;107(6):798-802.

13.

Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes.

Funamoto M, Fujio Y, Kunisada K, Negoro S, Tone E, Osugi T, Hirota H, Izumi M, Yoshizaki K, Walsh K, Kishimoto T, Yamauchi-Takihara K.

J Biol Chem. 2000 Apr 7;275(14):10561-6.

16.

STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.

Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3963-6.

17.

Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy.

Kodama H, Fukuda K, Pan J, Sano M, Takahashi T, Kato T, Makino S, Manabe T, Murata M, Ogawa S.

Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1635-44.

18.

Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.

Majka M, Ratajczak J, Villaire G, Kubiczek K, Marquez LA, Janowska-Wieczorek A, Ratajczak MZ.

Exp Hematol. 2002 Jul;30(7):751-60.

PMID:
12135673
19.

Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.

Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P.

FEBS Lett. 2000 Jul 28;478(1-2):100-4.

Supplemental Content

Support Center